대한한의학회지 (The Journal of Korean Medicine)

  • 제43권4호
  • /
  • Pages.102-130
  • /
  • 2022
  • /
  • 1010-0695(pISSN)
  • /
  • 2288-3339(eISSN)
대한한의학회 (The Society of Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

Managing Mental Health during the COVID-19 Pandemic: Recommendations from the Korean Medicine Mental Health Center

  • Hyo-Weon Suh (Health Policy Research Team, Division of Healthcare Research, National Evidence-based Healthcare Collaborating Agency) ;
  • Sunggyu Hong (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Hyun Woo Lee (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Seok-In Yoon (Department of Neuropsychiatry, College of Korean Medicine, Kyung Hee University) ;
  • Misun Lee (Kyung Hee University Industry Academic Cooperation Foundation) ;
  • Sun-Yong Chung (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Jong Woo Kim (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University)
  • 투고 : 2022.10.20
  • 심사 : 2022.11.15
  • 발행 : 2022.12.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: The persistence and unpredictability of coronavirus disease (COVID-19) and new measures to prevent direct medical intervention (e.g., social distancing and quarantine) have induced various psychological symptoms and disorders that require self-treatment approaches and integrative treatment interventions. To address these issues, the Korean Medicine Mental Health (KMMH) center developed a field manual by reviewing previous literature and preexisting manuals. Methods: The working group of the KMMH center conducted a keyword search in PubMed in June 2021 using "COVID-19" and "SARS-CoV-2". Review articles were examined using the following filters: "review," "systematic review," and "meta-analysis." We conducted a narrative review of the retrieved articles and extracted content relevant to previous manuals. We then created a treatment algorithm and recommendations by referring to the results of the review. Results: During the initial assessment, subjective symptom severity was measured using a numerical rating scale, and patients were classified as low- or moderate-high risk. Moderate-high-risk patients should be classified as having either a psychiatric emergency or significant psychiatric condition. The developed manual presents appropriate psychological support for each group based on the following dominant symptoms: tension, anxiety-dominant, anger-dominant, depression-dominant, and somatization. Conclusions: We identified the characteristics of mental health problems during the COVID-19 pandemic and developed a clinical mental health support manual in the field of Korean medicine. When symptoms meet the diagnostic criteria for a mental disorder, doctors of Korean medicine can treat the patients according to the manual for the corresponding disorder.

키워드

참고문헌

  1. National Center for Disaster and Trauma. (2020). Psychological support guideline for novel corona virus. Ministry of Health and Welfare.
  2. World Health Organization. ( 2021) . COVID-19 weekly epidemiological update, edition 68, 30 November 2021. https://apps.who.int/iris/handle/10665/350006.
  3. Han, R.H., Schmidt, M.N., Waits, W.M., Bell, A.K., & Miller, T.L. (2020). Planning for mental health needs during COVID-19. Curr Psychiatry Rep, 22(12), 1-10. https://doi.org/10.1007/s11920-020-01189-6.
  4. Robillard, R., Saad, M., Edwards, J., Solomonova, E., Pennestri, M. H., Daros, A., Veissiere, S. P. L., Quilty, L., Dion, K., Nixon, A., Phillips, J., Bhatla, R., Spilg, E., Godbout, R., Yazji, B., Rushton, C., Gifford, W. A., Gautam, M., Boafo, A., Swartz, R., & Kendzerska, T. (2020). Social, financial and psychological stress during an emerging pandemic: observations from a population survey in the acute phase of COVID-19. BMJ open, 10(12), e043805. http://dx.doi.org/10.1136/bmjopen2020-043805.
  5. Galbraith, N., Boyda, D., McFeeters, D., & Hassan, T. (2021). The mental health of doctors during the COVID-19 pandemic. BJPsych bulletin, 45(2), 93-97. https://doi.org/10.1192/bjb.2020.44.
  6. Kathirvel, N. (2020). Post COVID-19 pandemic mental health challenges. Asian J Psychiatr, 53, 102430. https://doi.org/10.1016/j.ajp.2020.102430.
  7. Wang, J., Mann, F., Lloyd-Evans, B., Ma, R., & Johnson, S. (2018). Associations between loneliness and perceived social support and outcomes of mental health problems: a systematic review. BMC psychiatry, 18(1), 1-16. https://doi.org/10.1186/s12888-018-1736-5.
  8. Ernst, M., Niederer, D., Werner, A. M., Czaja, S. J., Mikton, C., Ong, A. D., Rosen, T., Brahler, E., & Beutel, M. E. (2022). Loneliness before and during the COVID-19 pandemic: A systematic review with meta-analysis. American Psychologist. https://doi.org/10.1037/amp0001005.
  9. Molteni, F., Ladini, R., Biolcati, F., Chiesi, A. M., Dotti Sani, G. M., Guglielmi, S., Maraffi, M., Pedrazzani, A., Segatti, P., & Vezzoni, C. (2021). Searching for comfort in religion: insecurity and religious behaviour during the COVID-19 pandemic in Italy. European Societies, 23(sup1), S704-S720. https://doi.org/10.1080/14616696.2020.1836383.
  10. Saltzman, L.Y., Hansel, T.C., & Bordnick, P.S. (2020). Loneliness, isolation, and social support factors in post-COVID-19 mental health. Psychol Trauma, 12(S1), S55-S57. https://doi.org/10.1037/tra0000703.
  11. Division of Mental Health Management, Ministry of Health and Welfare. (2021). Q2 2021 "COVID19 National Mental Health Survey" Results Report. Ministry of Health and Welfare.
  12. National Medical Center. (2021). 2021 "COVID-19 Public Awareness Survey" Results Report. National Medical Center.
  13. Andrade, G., Simoes do Couto, F., & Camara-Pestana, L. (2020). Recommendations about the use of psychotropic medications during the COVID-19 pandemic. Acta Med Port, 33(10), 693-702. https://doi.org/10.20344/amp.13976.
  14. Danta, C.C. (2020). Calcium channel blockers: a possible potential therapeutic strategy for the treatment of Alzheimer's dementia patients with SARS-CoV-2 infection. ACS Chem Neurosci, 11(15), 2145-2148. https://doi.org/10.1021/acschemneuro.0c00391.
  15. Sabe, M., Dorsaz, O., Huguelet, P., & Kaiser, S. (2021). Toxicity of psychotropic drugs in patients with COVID-19: a systematic review. Gen Hosp Psychiatry, 70, 1-9. https://doi.org/10.1016/j.genhosppsych.2021.02.006.
  16. Bilbul, M., Paparone, P., Kim, A.M., Mutalik, S., & Ernst, C.L. (2020). Psychopharmacology of COVID-19. Psychosomatics, 61(5), 411-427. https://doi.org/10.1016/j.psym.2020.05.006.
  17. Rogers, J.P., Chesney, E., Oliver, D., Pollak, T.A., McGuire, P., Fusar-Poli, P., Zandi, M.S., Lewis, G., & David, A.S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry, 7(7), 611-627. https://doi.org/10.1016/S2215-0366(20)30203-0.
  18. Werner, E.A., Aloisio, C.E., Butler, A.D., D'Antonio, K.M., Kenny, J.M., Mitchell, A., Ona, S., & Monk, C. (2020). Addressing mental health in patients and providers during the COVID-19 pandemic. Semin Perinatol, 44(7), 151279. https://doi.org/10.1016/j.semperi.2020.151279.
  19. Jang, S., Kim, D., Yi, E., Choi, G., Song, M., & Lee, E.-K. (2021). Telemedicine and the use of Korean medicine for patients with COVID-19 in South Korea: observational study. JMIR Public Health Surveill, 7(1), e20236. https://doi.org/10.2196/20236.
  20. Kim, D.-S., Chu, H., Min, B.K., Moon, Y., Park, S., Kim, K., Park, S.-H., Kim, Y.-D., Song, M., Choi, G.-H., & Lee, E. (2020). Telemedicine center of Korean medicine for treating patients with COVID-19: a retrospective analysis. Integr Med Res, 9(3), 100492. https://doi.org/10.1016/j.imr.2020.100492.
  21. Kwon, C.-Y., Kwak, H.-Y., & Kim, J.W. (2020). Using mind-body modalities via telemedicine during the COVID-19 crisis: cases in the Republic of Korea. Int J Environ Res Public Health, 17(12), 4477. https://doi.org/10.3390/ijerph17124477.
  22. Jain, F. A., Walsh, R. N., Eisendrath, S. J., Christensen, S., & Cahn, B. R. (2015). Critical analysis of the efficacy of meditation therapies for acute and subacute phase treatment of depressive disorders: a systematic review. Psychosomatics, 56(2), 140-152. https://doi.org/10.1016/j.psym.2014.10.007.
  23. McCartney, M., Nevitt, S., Lloyd, A., Hill, R., White, R., & Duarte, R. (2021). Mindfulness-based cognitive therapy for prevention and time to depressive relapse: Systematic review and network meta-analysis. Acta Psychiatrica Scandinavica, 143(1), 6-21. https://doi.org/10.1111/acps.13242.
  24. Vollestad, J., Nielsen, M. B., & Nielsen, G. H. (2012). Mindfulness-and acceptance-based interventions for anxiety disorders: A systematic review and meta-analysis. British journal of clinical psychology, 51(3), 239-260. https://doi.org/10.1111/j.2044-8260.2011.02024.x.
  25. Zhou, X., Guo, J., Lu, G., Chen, C., Xie, Z., Liu, J., & Zhang, C. (2020). Effects of mindfulness-based stress reduction on anxiety symptoms in young people: A systematic review and meta-analysis. Psychiatry Research, 289, 113002. https://doi.org/10.1016/j.psychres.2020.113002.
  26. Hilton, L., Maher, A. R., Colaiaco, B., Apaydin, E., Sorbero, M. E., Booth, M., Marika, S., Roberta, M., & Hempel, S. (2017). Meditation for posttraumatic stress: Systematic review and meta-analysis. Psychological Trauma: Theory, Research, Practice, and Policy, 9(4), 453. https://doi.org/10.1037/tra0000180.
  27. Goyal, M., Singh, S., Sibinga, E. M. S., Gould, N. F., Rowland-Seymour, A., Sharma, R., Berger, Z., Sleicher, D., Maron, D. D., Shihab H. M., Ranasinghe, P. D., Linn, S., Saha, S., Bass, E. B., & Haythornthwaite, J. A. (2014). Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA internal medicine, 174(3), 357-368. doi:10.1001/jamainternmed.2013.13018.
  28. Sharma, M., & Rush, S. E. (2014). Mindfulness-based stress reduction as a stress management intervention for healthy individuals: a systematic review. Journal of evidence-based complementary & alternative medicine, 19(4), 271-286. https://doi.org/10.1177/2156587214543143.
  29. Pascoe, M. C., Thompson, D. R., Jenkins, Z. M., & Ski, C. F. (2017). Mindfulness mediates the physiological markers of stress: Systematic review and meta-analysis. Journal of psychiatric research, 95, 156-178. https://doi.org/10.1016/j.jpsychires.2017.08.004.
  30. Rusch, H. L., Rosario, M., Levison, L. M., Olivera, A., Livingston, W. S., Wu, T., & Gill, J. M. (2019). The effect of mindfulness meditation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. Annals of the New York Academy of Sciences, 1445(1), 5-16. https://doi.org/10.1111/nyas.13996.
  31. EBM-based Guidelines Development Committee for Korean Medicine Clinical Practice Guideline for Depression (Korea Institute of Oriental Medicine and Society of Korean Medicine Neuropsychiatry). (2016). Korean Medicine Clinical Practice Guideline for Depression. Deajeon, Korea: Elsevier Korea.
  32. The Society of Korean Medicine Neuropsychiatry. (2021). Clinical practice guideline of Korean medicine for anxiety disorders. Guideline Center for Korean Medicine (G-KoM), National Development Institute of Korean Medicine.
  33. The Society of Korean Medicine Neuropsychiatry. (2021). Clinical practice guideline of Korean medicine for insomnia disorder. Guideline Center for Korean Medicine (G-KoM), National Development Institute of Korean Medicine.
  34. The Society of Korean Medicine Neuropsychiatry. Clinical practice guideline of Korean medicine for Hwabyung. 2021: Guideline Center for Korean Medicine (G-KoM), National Development Institute of Korean Medicine.
  35. Kwon, C. Y., Seo, J., & Kim, S. H. (2022). Development of a Manual for Disaster Medical Support Using Korean Medicine for Disaster Survivors. Journal of integrative and complementary medicine. https://doi.org/10.1089/jicm.2022.0561.
  36. Behan, C. (2020). The benefits of meditation and mindfulness practices during times of crisis such as COVID-19. Irish journal of psychological medicine, 37(4), 256-258. https://doi.org/10.1017/ipm.2020.38
  37. Jimenez, O., Sanchez-Sanchez, L. C., & Garcia-Montes, J. M. (2020). Psychological impact of COVID-19 confinement and its relationship with meditation. International Journal of Environmental Research and Public Health, 17(18), 6642. https://doi.org/10.3390/ijerph17186642.
  38. Rasania, S. K. (2021). A cross--sectional study of mental wellbeing with practice of yoga and meditation during COVID-19 pandemic. Journal of Family Medicine and Primary Care, 10(4), 1576. doi: 10.4103/jfmpc.jfmpc_2367_20
  39. Hossain, M.M., Tasnim, S., Sultana, A., Faizah, F., Mazumder, H., Zou, L., McKyer, E.L.J., Ahmed, H.U., & Ma, P. (2020). Epidemiology of mental health problems in COVID-19: a review. F1000Res, 9, 636. https://doi.org/10.12688/f1000research.24457.1.
  40. Chevance, A., Gourion, D., Hoertel, N., Llorca, P.M., Thomas, P., Bocher, R., Moro, M.R., Laprevote, V., Benyamina, A., Fossati, P., Masson, M., Leaune, E., Leboyer, M., & Gaillard, R. (2020). Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review. Encephale, 46(3), 193- 201. https://doi.org/10.1016/j.encep.2020.04.005.
  41. Silva, A.F.D., Estrela, F.M., Soares, C.F.S., Magalhaes, J.R.F.D., Lima, N.S., Morais, A.C., Gomes, N.P., & Lima, V.L.D.A. (2020). Marital violence precipitating/intensifying elements during the Covid-19 pandemic. Cien Saude Colet, 25(9), 3475-3480. https://doi.org/10.1590/1413-81232020259.16132020.
  42. Gilan, D., Rothke, N., Blessin, M., Kunzler, A., Stoffers-Winterling, J., Mussig, M., Yuen, K.S.L., Tuscher, O., Thrul, J., Kreuter, F., Sprengholz, P., Betsch, C., Stieglitz, R.D., & Lieb, K. (2020). Psychomorbidity, resilience, and exacerbating and protective factors during the SARS -CoV-2 pandemic. Dtsch Arztebl Int, 117(38), 625-630. https://doi.org/10.3238/ arztebl. 2020.0625.
  43. Kunzler, A.M., Rothke, N., Gunthner, L., Stoffers-Winterling, J., Tuscher, O., Coenen, M., Rehfuess, E., Schwarzer, G., Binder, H., Schmucker, C., Meerpohl, J.J., & Lieb, K. (2021). Mental burden and its risk and protective factors during the early phase of the SARS-CoV-2 pandemic: systematic review and meta-analyses. Global Health, 17(1), 34. https://doi.org/10.1186/s12992-021-00670-y.
  44. Taylor, S. (2021). COVID stress syndrome: clinical and nosological considerations. Curr Psychiatry Rep, 23(4), 19. https://doi.org/10.1007/s11920-021-01226-y.
  45. Xiong, J., Lipsitz, O., Nasri, F., Lui, L.M.W., Gill, H., Phan, L., Chen-Li, D., Iacobucci, M., Ho, R., Majeed, A., & McIntyre, R.S. (2020). Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord, 277, 55-64. https://doi.org/10.1016/j.jad.2020.08.001.
  46. Heiat, M., Heiat, F., Halaji, M., Ranjbar, R., Tavangar Marvasti, Z., Yaali-Jahromi, E., Azizi, M.M., Morteza Hosseini, S., & Badri, T. (2021). Phobia and fear of COVID-19: origins, complications and management, a narrative review. Ann Ig, 33(4), 360-370. https://doi.org/10.7416/ai.2021.2446.
  47. Brooks, S.K., Webster, R.K., Smith, L.E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G.J. (2020). The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet, 395(10227), 912-920. https://doi.org/10.1016/S0140-6736(20)30460-8.
  48. Chaimowitz, G.A., Upfold, C., Gea, L.P., Qureshi, A., Moulden, H.M., Mamak, M., & Bradford, J.M.W. (2021). Stigmatization of psychiatric and justice-involved populations during the COVID-19 pandemic. Prog Neuropsychopharmacol Biol Psychiatry, 106, 110150. https://doi.org/10.1016/j.pnpbp.2020.110150.
  49. de Figueiredo, C.S., Sandre, P.C., Portugal, L.C.L., Mazala-de-Oliveira, T., da Silva Chagas, L., Raony, I., Ferreira, E.S., Giestal-de-Araujo, E., Dos Santos, A.A., & Bomfim, P.O. (2021). COVID-19 pandemic impact on children and adolescents' mental health: biological, environmental, and social factors. Prog Neuropsychopharmacol Biol Psychiatry, 106, 110171. https://doi.org/10.1016/j.pnpbp.2020.110171.
  50. Kotlar, B., Gerson, E., Petrillo, S., Langer, A., & Tiemeier, H. (2021). The impact of the COVID-19 pandemic on maternal and perinatal health: a scoping review. Reprod Health, 18(1), 10. https://doi.org/10.1186/s12978-021-01070-6.
  51. Grolli, R.E., Mingoti, M.E.D., Bertollo, A.G., Luzardo, A.R., Quevedo, J., Reus, G.Z., & Ignacio, Z.M. (2021). Impact of COVID-19 in the mental health in elderly: psychological and biological updates. Mol Neurobiol, 58(5), 1905-1916. https://doi.org/10.1007/s12035-020-02249-x.
  52. Mosolov, S.N., (2020). Problems of mental health in the situation of COVID-19 pandemic. Zh Nevrol Psikhiatr Im S S Korsakova, 120(5), 7-15. https://doi.org/10.17116/jnevro20201200517.
  53. Vanessa, C.F., & Iarocci, G. (2020). Child and family outcomes following pandemics: a systematic review and recommendations on COVID-19 policies. J Pediatr Psychol, 45(10), 1124-1143. https://doi.org/10.1093/jpepsy/jsaa092.
  54. Cabrera, M.A., Karamsetty, L., & Simpson, S.A. (2020). Coronavirus and its implications for psychiatry: a rapid review of the early literature. Psychosomatics, 61(6), 607-615. https://doi.org/10.1016/j.psym.2020.05.018.
  55. Mazhar, K., Hussain, S., Ullah, R., Raza, H., Aamir, A., Asif, A., Memon, F.S., Haider, J., & Anas, M. (2020). Mental health crisis in pregnant women during current COVID-19 pandemic. Psychiatr Danub, 32(3-4), 598-599.
  56. Cosco, T.D., Fortuna, K., Wister, A., Riadi, I., Wagner, K., & Sixsmith, A. (2021). COVID-19, social isolation, and mental health among older adults: a digital catch-22. J Med Internet Res, 23(5), e21864. https://doi.org/10.2196/21864.
  57. da Silva, F.C.T., & Neto, M.L.R. (2021). Psychiatric symptomatology associated with depression, anxiety, distress, and insomnia in health professionals working in patients affected by COVID-19: a systematic review with meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry, 104, 110057. https://doi.org/10.1016/j.pnpbp.2020.110057.
  58. da Silva, F.C.T., & Neto, M.L.R. (2021). Psychological effects caused by the COVID-19 pandemic in health professionals: a systematic review with meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry, 104, 110062. https://doi.org/10.1016/j.pnpbp.2020.110062.
  59. Varghese, A., George, G., Kondaguli, S.V., Naser, A.Y., Khakha, D.C., & Chatterji, R. (2021). Decline in the mental health of nurses across the globe during COVID-19: a systematic review and meta-analysis. J Glob Health, 11, 05009. https://doi.org/10.7189/jogh.11.05009.
  60. d'Ettorre, G., Ceccarelli, G., Santinelli, L., Vassalini, P., Innocenti, G.P., Alessandri, F., Koukopoulos, A.E., Russo, A., d'Ettorre, G., & Tarsitani, L. (2021). Post-traumatic stress symptoms in healthcare workers dealing with the COVID-19 pandemic: a systematic review. Int J Environ Res Public Health, 18(2), 601. https://doi.org/10.3390/ijerph18020601.
  61. Junior, J.G., Moreira, M.M., Pinheiro, W.R., de Amorim, L.M., Lima, C.K.T., da Silva, C.G.L., & Neto, M.L.R. (2020). The mental health of those whose rights have been taken away: an essay on the mental health of indigenous peoples in the face of the 2019 coronavirus (2019-nCoV) outbreak. Psychiatry Res, 289, 113094. https://doi.org/10.1016/j.psychres.2020.113094.
  62. Furlong, Y., & Finnie, T. (2020). Culture counts: the diverse effects of culture and society on mental health amidst COVID-19 outbreak in Australia. Ir J Psychol Med, 37(3), 237-242. https://doi.org/10.1017/ipm.2020.37.
  63. Rothman, S., Gunturu, S., & Korenis, P., The mental health impact of the COVID-19 epidemic on immigrants and racial and ethnic minorities. QJM, 113(11), 779-782. https://doi.org/10.1093/qjmed/hcaa203.
  64. Mukherjee, S. (2020). Disparities, desperation, and divisiveness: coping with COVID-19 in India. Psychol Trauma, 12(6), 582-584. https://doi.org/10.1037/tra0000682.
  65. Almeida, M., Shrestha, A.D., Stojanac, D., & Miller, L.J. (2020). The impact of the COVID-19 pandemic on women's mental health. Arch Womens Ment Health, 23(6), 741-748. https://doi.org/10.1007/s00737-020-01092-2.
  66. Esterwood, E., & Saeed, S.A. (2020). Past epidemics, natural disasters, COVID19, and mental health: learning from history as we deal with the present and prepare for the future. Psychiatr Q, 91(4), 1121-1133. https://doi.org/10.1007/s11126-020-09808-4.
  67. Mengin, A., Alle, M.C., Rolling, J., Ligier, F., Schroder, C., Lalanne, L., Berna, F., Jardri, R., Vaiva, G., Geoffroy, P.A., Brunault, P., Thibaut, F., Chevance, A., & Giersch, A. (2020). Psychopathological consequences of confinement. Encephale, 46(3S), S43-S52. https://doi.org/10.1016/j.encep.2020.04.007.
  68. Chew, Q.H., Wei, K.C., Vasoo, S., Chua, H.C., & Sim, K. (2020). Narrative synthesis of psychological and coping responses towards emerging infectious disease outbreaks in the general population: practical considerations for the COVID-19 pandemic. Singapore Med J, 61(7), 350-356. https://doi.org/10.11622/smedj.2020046.
  69. Henssler, J., Stock, F., van Bohemen, J., Walter, H., Heinz, A., & Brandt, L. (2021). Mental health effects of infection containment strategies: quarantine and isolation-a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci, 271(2), 223-234. https://doi.org/10.1007/s00406-020-01196-x.
  70. Blum, K., Cadet, J.L., Baron, D., Badgaiyan, R.D., Brewer, R., Modestino, E.J., & Gold, M.S. (2020). Putative COVID-19 induction of reward deficiency syndrome (RDS) and associated behavioral addictions with potential concomitant dopamine depletion: is COVID-19 social distancing a double edged sword?. Subst Use Misuse, 55(14), 2438-2442. https://doi.org/10.1080/10826084.2020.1817086.
  71. Sher, L. (2020). The impact of the COVID-19 pandemic on suicide rates. QJM, 113(10), 707-712. https://doi.org/10.1093/qjmed/hcaa202.
  72. Fatke, B., Holzle, P., Frank, A., & Forstl, H. (2020). COVID-19 crisis: early observations on a pandemic's psychiatric problems. Dtsch Med Wochenschr, 145(10), 675-681. https://doi.org/10.1055/a-1147-2889.
  73. Anjum, S., Ullah, R., Rana, M.S., Khan, H.A., Memon, F.S., Ahmed, Y., Jabeen, S., & Faryal, R. (2020). COVID-19 pandemic: a serious threat for public mental health globally. Psychiatr Danub, 32(2), 245-250. https://doi.org/10.24869/psyd.2020.245.
  74. Mallet, J., Dubertret, C., & Le Strat, Y. (2021). Addictions in the COVID-19 era: current evidence, future perspectives a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry, 106, 110070. https://doi.org/10.1016/j.pnpbp.2020.110070.
  75. Bailey, K.L., Samuelson, D.R., & Wyatt, T.A. (2021). Alcohol use disorder: a pre-existing condition for COVID-19?. Alcohol, 90, 11-17. https://doi.org/10.1016/j.alcohol.2020.10.003.
  76. He, Y., Yu, R., & Ren, J. (2021). The correlation between psychiatric disorders and COVID-19: a narrative review. Psychiatr Danub, 33(1), 76-85. https://doi.org/10.24869/psyd.2021.76.
  77. Preti, E., Di Pierro, R., Fanti, E., Madeddu, F., & Calati, R. (2020). Personality disorders in time of pandemic. Curr Psychiatry Rep, 22(12), 80. https://doi.org/10.1007/s11920-020-01204-w.
  78. Sulaimani, M.F., & Bagadood, N.H. Implication of coronavirus pandemic on obsessive-compulsive-disorder symptoms. Rev Environ Health, 36(1), 1-8. https://doi.org/10.1515/reveh-2020-0054.
  79. Salehi, M., Amanat, M., Mohammadi, M., Salmanian, M., Rezaei, N., Saghazadeh, A., & Garakani, A. (2021). The prevalence of post-traumatic stress disorder related symptoms in coronavirus outbreaks: a systematic-review and meta-analysis. J Affect Disord, 282, 527-538. https://doi.org/10.1016/j.jad.2020.12.188.
  80. Cooke, J.E., Eirich, R., Racine, N., Madigan, S. (2020). Prevalence of posttraumatic and general psychological stress during COVID-19: a rapid review and meta-analysis. Psychiatry Res, 292, 113347. https://doi.org/10.1016/j.psychres.2020.113347.
  81. da Silva, M.L., Rocha, R.S.B., Buheji, M., Jahrami, H., & Cunha, K.D.C. (2021). A systematic review of the prevalence of anxiety symptoms during coronavirus epidemics. J Health Psychol, 26(1), 115-125. https://doi.org/10.1177/1359105320951620.
  82. Numbers, K., & Brodaty, H. (2021). The effects of the COVID-19 pandemic on people with dementia. Nat Rev Neurol, 17(2), 69-70. https://doi.org/10.1038/s41582-020-00450-z.
  83. Iodice, F., Cassano, V., & Rossini, P.M. (2021). Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer's disease populations. Neurol Sci, 42(2), 455-465. https://doi.org/10.1007/s10072-020-04902-8.
  84. Javelot, H., & Weiner, L. (2021) Panic and pandemic: narrative review of the literature on the links and risks of panic disorder as a consequence of the SARS-CoV-2 pandemic. Encephale, 47(1), 38-42. https://doi.org/10.1016/j.encep.2020.08.001.
  85. Hernandez-Gomez, A., Andrade-Gonzalez, N., Lahera, G., & Vieta, E. (2021) Recommendations for the care of patients with bipolar disorder during the COVID-19 pandemic. J Affect Disord, 279, 117-121. https://doi.org/10.1016/j.jad.2020.09.105.
  86. Costanza, A., Di Marco, S., Burroni, M., Corasaniti, F., Santinon, P., Prelati, M., Chytas, V., Cedraschi, C., & Ambrosetti, J. (2020). Meaning in life and demoralization: a mental-health reading perspective of suicidality in the time of COVID-19. Acta Biomed, 91(4), e2020163. https://doi.org/10.23750/abm.v91i4.10515.
  87. Conejero, I., Berrouiguet, S., Ducasse, D., Leboyer, M., Jardon, V., Olie, E., & Courtet, P. (2020). Suicidal behavior in light of COVID-19 outbreak: clinical challenges and treatment perspectives. Encephale, 46(3S), S66-S72. https://doi.org/10.1016/j.encep.2020.05.001.
  88. Walsh, O., & McNicholas, F. (2020). Assessment and management of anorexia nervosa during COVID-19. Ir J Psychol Med. 37(3), 187-191. https://doi.org/10.1017/ipm.2020.60.
  89. Jahrami, H., BaHammam, A.S., Bragazzi, N.L., Saif, Z., Faris, M., & Vitiello, M.V. (2021). Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. J Clin Sleep Med, 17(2), 299-313. https://doi.org/10.5664/jcsm.8930.
  90. Datta, K., & Tripathi, M. (2021). Sleep and Covid-19. Neurol India, 69(1), 26-31. https://doi.org/10.4103/0028-3886.310073.
  91. Souza, L.F.F., Paineiras-Domingos, L.L., Melo-Oliveira, M.E.S., Pessanha-Freitas, J., Moreira-Marconi, E., Lacerda, A.C.R., Mendonca, V.A., Sa-Caputo, D.D.C., & Bernardo-Filho, M. (2021). The impact of COVID-19 pandemic in the quality of sleep by Pittsburgh Sleep Quality Index: a systematic review. Cien Saude Colet, 26(4), 1457-1466. https://doi.org/10.1590/1413-81232021264.45952020.
  92. Kim, S.W., & Su, K.P. (2020). Using psychoneuroimmunity against COVID-19. Brain Behav Immun, 87, 4-5. https://doi.org/10.1016/j.bbi.2020.03.025.
  93. Puyat, J.H., Ahmad, H., Avina-Galindo, A.M., Kazanjian, A., Gupta, A., Ellis, U., Ashe, M.C., Vila-Rodriguez, F., Halli, P., Salmon, A., Vigo, D., Almeida, A., & De Bono, C.E. (2020). A rapid review of home-based activities that can promote mental wellness during the COVID-19 pandemic. PLoS One, 15(12), e0243125. https://doi.org/10.1371/journal.pone.0243125.
  94. Hou, W.K., Lai, F.T., Ben-Ezra, M., & Goodwin, R. (2020). Regularizing daily routines for mental health during and after the COVID-19 pandemic. J Glob Health, 10(2), 020315. https://doi.org/10.7189/jogh.10.020315.
  95. Jakovljevic, M., Jakovljevic, I., Bjedov, S., & Mustac, F. (2020). Psychiatry for better world: COVID-19 and blame games people play from public and global mental health perspective. Psychiatr Danub, 32(2), 221-228. https://doi.org/10.24869/psyd.2020.221.
  96. Blanc, J., Briggs, A.Q., Seixas, A.A., Reid, M., Jean-Louis, G., & Pandi-Perumal, S.R. (2021). Addressing psychological resilience during the coronavirus disease 2019 pandemic: a rapid review. Curr Opin Psychiatry, 34(1), 29-35. https://doi.org/10.1097/YCO.0000000000000665.
  97. Williams, C.Y.K., Townson, A.T., Kapur, M., Ferreira, A.F., Nunn, R., Galante, J., Phillips, V., Gentry, S., & Usher-Smith, J.A. (2021). Interventions to reduce social isolation and loneliness during COVID-19 physical distancing measures: a rapid systematic review. PLoS One, 16(2), e0247139. https://doi.org/10.1371/journal.pone.0247139.
  98. Prisco, V., Prisco, L., & Donnarumma, B. (2020). Telepsychiatry in adults and adolescents: a useful tool against CoViD-19. Recenti Prog Med, 111(7), 411-414. https://doi.org/10.1701/3407.33923.
  99. Di Carlo, F., Sociali, A., Picutti, E., Pettorruso, M., Vellante, F., Verrastro, V., Martinotti, G., & di Giannantonio, M. (2021). Telepsychiatry and other cutting-edge technologies in COVID-19 pandemic: bridging the distance in mental health assistance. Int J Clin Pract, 75(1), 10.1111/ijcp.13716. https://doi.org/10.1111/ijcp.13716.
  100. Yue, J.L., Yan, W., Sun, Y.K., Yuan, K., Su, S.Z., Han, Y., Ravindran, A.V., Kosten, T., Everall, I., Davey, C.G., Bullmore, E., Kawakami, N., Barbui, C., Thornicroft, G., Lund, C., Lin, X., Liu, L., Shi, L., Shi, J., Ran, M.S., Bao, Y.P., & Lu, L. (2020). Mental health services for infectious disease outbreaks including COVID-19: a rapid systematic review. Psychol Med, 50(15), 2498-2513. https://doi.org/10.1017/S0033291720003888.
  101. Zhang, M., & Smith, H.E. (2020). Digital tools to ameliorate psychological symptoms associated with COVID-19: scoping review. J Med Internet Res, 22(8), e19706. https://doi.org/10.2196/19706.
  102. Simpson, S., Richardson, L., Pietrabissa, G., Castelnuovo, G., & Reid, C. (2021). Videotherapy and therapeutic alliance in the age of COVID-19. Clin Psychol Psychother, 28(2), 409-421. https://doi.org/10.1002/cpp.2521.
  103. Monroy-Fraustro, D., Maldonado-Castellanos, I., Aboites-Molina, M., Rodriguez, S., Sueiras, P., Altamirano-Bustamante, N.F., de Hoyos-Bermea, A., & Altamirano-Bustamante, M.M. (2021). Bibliotherapy as a non-pharmaceutical intervention to enhance mental health in response to the COVID-19 pandemic: a mixed-methods systematic review and bioethical meta-analysis. Front Public Health, 9, 629872. https://doi.org/10.3389/fpubh.2021.629872.
  104. Ma, K., Wang, X., Feng, S., Xia, X., Zhang, H., Rahaman, A., Dong, Z., Lu, Y., Li, X., Zhou, X., Zhao, H., Wang, Y., Wang, S., & Baloch, Z. (2020). From the perspective of traditional Chinese medicine: treatment of mental disorders in COVID-19 survivors. Biomed Pharmacother, 132, 110810. https://doi.org/10.1016/j.biopha.2020.110810.
  105. Shahrajabian, M.H., Sun, W., Soleymani, A., & Cheng, Q. (2021). Traditional herbal medicines to overcome stress, anxiety and improve mental health in outbreaks of human coronaviruses. Phytother Res, 35(3), 1237-1247. https://doi.org/10.1002/ptr.6888.
  106. Park, J.E., Kang, S.-H., Won, S.-D, Roh, D., & Kim, W.-H. (2015). Assessment instruments for disaster behavioral health. Anxiety and Mood, 11(2), 91-105.
  107. Cameron, R. P., & Gusman, D. (2003). The primary care PTSD screen (PC-PTSD): development and operating characteristics. Primary care psychiatry, 9(1), 9-14.
  108. Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: validity of a brief depression severity measure. Journal of general internal medicine, 16(9), 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x.
  109. Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn, J., Kerse, N., Fishman, T., Falloon, H., & Hatcher, S. (2010). Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. The annals of family medicine, 8(4), 348-353. https://doi.org/10.1370/afm.1139
  110. Martin, A., Rief, W., Klaiberg, A., & Braehler, E. (2006). Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. General hospital psychiatry, 28(1), 71-77. https://doi.org/10.1016/j.genhosppsych.2005.07.003.
  111. Park, S. J., Choi, H. R., Choi, J. H., Kim, K. W., & Hong, J. P. (2010). Reliability and validity of the Korean version of the Patient Health Questionnaire-9 (PHQ-9). Anxiety and mood, 6(2), 119-124.
  112. Spitzer, R. L., Kroenke, K., Williams, J. B., & Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of internal medicine, 166(10), 1092-1097. doi:10.1001/archinte.166.10.1092
  113. Lowe, B., Decker, O., Muller, S., Brahler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008). Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Medical care, 266-274. https://www.jstor.org/stable/40221654.
  114. Lee, S. H., Shin, C., Kim, H., Jeon, S. W., Yoon, H. K., Ko, Y. H., Pae, C., U., & Han, C. (2022). Validation of the Korean version of the generalized anxiety disorder 7 self-rating scale. Asia-Pacific Psychiatry, 14(1), e12421. https://doi.org/10.1111/appy.12421.
  115. Kroenke, K., Spitzer, R. L., & Williams, J. B. (2002). The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosomatic medicine, 64(2), 258-266. https://doi.org/10.1097/00006842-200203000-00008
  116. van Ravesteijn, H., Wittkampf, K., Lucassen, P., van de Lisdonk, E., van den Hoogen, H., van Weert, H., Huijser, J., Schene, A., van Weel, C., & Speckens, A. (2009). Detecting somatoform disorders in primary care with the PHQ-15. The Annals of Family Medicine, 7(3), 232-238. https://doi.org/10.1370/afm.985.
  117. Kocalevent, R. D., Hinz, A., & Brahler, E. (2013). Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population. BMC psychiatry, 13(1), 1-8. https://doi.org/10.1186/1471-244X-13-91.
  118. Han, C., Pae, C. U., Patkar, A. A., Masand, P. S., Kim, K. W., Joe, S. H., & Jung, I. K. (2009). Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. Psychosomatics, 50(6), 580-585. https://doi.org/10.1016/S0033-3182(09)70859-X.
  119. Lee, S., Huh, Y., & Kim, J. (2014). Finding optimal cut off points of the Korean version of the Patient Health Questionnaire-9 (PHQ-9) for screening depressive disorders. Mood Emot, 12(1), 32-36.
  120. Kyung Hee University Korean Medicine Hospital at Gangdong. (2020). Manual for doctors of Korean medicine at COVID-19 treatment sites.
  121. Pfefferbaum, B., & North, C.S. (2020). Mental health and the Covid-19 pandemic. New England Journal of Medicine, 383(6), 510-512. https://doi.org/10.1056/NEJMp2008017.
  122. Kwon, J. H., Kim, J. W., Park, D. G., Lee, M. S., Min, S. G., & Kwon, H. I. (2008). Development and validation of the Hwa-Byung Scale. The Korean Journal of Clinical Psychology, 27(1), 237-252. https://doi.org/10.15842/kjcp.2008.27.1.014
  123. Lee, Y., Baek, Y., Park, K., Jin, H. J., & Lee, S. (2016). Development and validation of an instrument to measure the health status of healthy but unsatisfied people: Mibyeong index (未病 index). Journal of Society of Preventive Korean Medicine, 20(3), 45-53.
  124. National Institute for Health and Care Excellence (NICE). (2014). Anxiety disorders Quality standard. NICE. Available from: www.nice.org.uk/guidance/qs53. (Accessed March 26 2020).
  125. National Institute for Health and Care Excellence (NICE). (2018). Posttraumatic stress disorder NICE guideline. NICE. Available from: www.nice.org.uk/guidance/ng116. (Accessed March 26 2020).
  126. Kwak, H. Y., Hong, S. G., & Kim, J. W. (2020). Research Trends in Mind-Body Intervention in the COVID-19 Pandemic. Korean Society for Meditation, 10(2), 53-71.